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Aim:  This  study  estimated  the  critical  closing  pressure  (CrCP)  of the  cerebrovascular  circulation  during
the  post-cardiac  arrest  syndrome  and  determined  if CrCP  differs  between  survivors  and  non-survivors.
We  also  compared  patients  after  cardiac  arrest  to normal  controls.
Methods:  A  prospective  observational  study  was  performed  at the ICU of  a tertiary  university  hospital
in  Nijmegen,  the  Netherlands.  We  studied  11 comatose  patients  successfully  resuscitated  from  a cardiac
arrest  and treated  with  mild  therapeutic  hypothermia  and  10 normal  control  subjects.  Mean  ﬂow  velocity
(MFV)  in  the middle  cerebral  artery  was  measured  by  transcranial  Doppler  at  several  time  points  after
admission  to  the ICU.  CrCP was  determined  by  a cerebrovascular  impedance  model.
Results:  MFV was  similar  in survivors  and non-survivors  upon  admission  to the ICU,  but  increased  stronger
in non-survivors  compared  to  survivors  throughout  the observation  period  (P  <  0.001).  MFV  was  signiﬁ-
cantly  lower  in survivors  immediately  after  cardiac  arrest  compared  to  normal  controls  (P <  0.001),  with
a gradual  restoration  toward  normal  values.  CrCP  decreased  signiﬁcantly  from  61.4[51.0–77.1]  mmHg  to
41.7[39.9–51.0]  mmHg  in  the  ﬁrst  48  h,  after  which  it remained  stable  (P < 0.001).  CrCP  was  signiﬁcantly
higher  in  survivors  compared  to non-survivors  (P = 0.002).  CrCP  immediately  after  cardiac  arrest  was
signiﬁcantly  higher  compared  to the  control  group  (P =  0.02).
Conclusions:  CrCP  is  high  after cardiac  arrest  with  high  cerebrovascular  resistance  and  low MFV.  This  sug-
gests  that  cerebral  perfusion  pressure  should  be maintained  at a sufﬁcient  high level  to  avoid  secondary
brain  injury.  Failure  to normalize  the cerebrovascular  proﬁle  may  be  a  parameter  of poor outcome.
© 2016  The  Authors.  Published  by  Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the  CC  BYntroductionPrognosis after cardiac arrest is mainly determined by the
eurological injury induced by the circulatory arrest. Return of
pontaneous circulation (ROSC) does not automatically restore
Abbreviations: ABP, arterial blood pressure; Ca, compliance; CABV, cerebral
rterial blood volume; CBF, cerebral blood ﬂow; CPP, cerebral perfusion pressure;
rCP, critical closing pressure; CVR, cerebrovascular resistance; HR, heart rate; ICP,
ntracranial pressure; MAP, mean arterial pressure; MCA, middle cerebral artery;
FV, mean ﬂow velocity; ROSC, return of spontaneous circulation; TCD, transcranial
oppler.
 A  Spanish translated version of the abstract of this article appears as Appendix
n  the ﬁnal online version at http://dx.doi.org/10.1016/j.resuscitation.2016.10.022.
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ax: +31 24 3541612.
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300-9572/© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access license  (http://creativecommons.org/licenses/by/4.0/).
cerebral perfusion. Cerebral perfusion failure after restoration of
circulation is a well known phenomenon in animal models with
no-reﬂow, cerebral hyperperfusion and hypoperfusion that ulti-
mately restores toward normal cerebral blood ﬂow (CBF).1 Humans
have a similar ﬂow pattern after cardiac arrest with low CBF in
the initial phase after cardiac arrest that gradually restores toward
normal values during the post-resuscitation syndrome.2–4 This so
called “delayed hypoperfusion phase” renders the brain at risk for
ischemia and secondary brain injury.
The cerebral vascular tone plays an essential role in changes
in CBF after cardiac arrest. Increased cerebrovascular resistance
has been suggested to contribute to the delayed hypoperfusion
phase, based on high transcranial Doppler pulsatility indexes
of the middle cerebral artery (MCA) measured during the early
post-cardiac arrest period.2–4 A subsequent strong decrease in tran-
scranial Doppler (TCD) pulsatility index with increased mean ﬂow
velocities (MFV) during the ﬁrst 24 h after the arrest was mea-
article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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ured in non-survivors, whereas in survivors these parameters
ormalized.5 In addition, autoregulation is disturbed in approxi-
ately 1/3 of patients after cardiac arrest, mainly in those with
 poor outcome.6,7 Taken together, these data indicate that the
erebrovascular resistance is altered after cardiac arrest, mainly in
atients with a poor neurological outcome.
The critical closing pressure (CrCP) is a method to describe and
uantify characteristics of the cerebrovascular bed in more detail
nd is deﬁned as the lower limit of arterial blood pressure below
hich vessels collapse and ﬂow ceases.8,9 Because CrCP cannot be
easured directly, several models have been developed to estimate
rCP indirectly from other measurable physiological parameters
r their derivatives. CrCP in the model of Burton is the sum of
ntracranial pressure (ICP) and vascular wall tension.8 Varsos et al.
roposed a modiﬁcation of the CrCP calculation, using a model
f cerebrovascular impedance. With this model, the generation of
egative values for CrCP is prevented and the model can accu-
ately detect changes in vascular properties induced by changes
n ICP, PaCO2 and blood pressure.10 CrCP is a valuable and clinically
elevant tool in cerebrovascular research, as it allows to estimate
hanges in cerebrovascular tone and minimal cerebral perfusion
ressure to prevent collapse of vessels and ischemia.11–13
The aim of the current study was to estimate CrCP of cerebrovas-
ular motor tone during the post-cardiac arrest syndrome and to
etermine if CrCP differs between survivors and non-survivors. To
lace these values in a broader context, we also compared CrCP in
ost-cardiac arrest patients to normal controls.
ethods
tudy
A prospective observational study was performed at the ICU of
 tertiary university hospital in the Netherlands. All experiments
ere in accordance with the Declaration of Helsinki and Good Clin-
cal Practice guidelines.
opulation
We  studied 11 comatose patients successfully resuscitated from
 cardiac arrest and treated with mild therapeutic hypothermia.
nclusion criteria were age ≥18 years and coma (Glasgow coma
cale ≤ 6) after return of spontaneous circulation. “Survivors” and
non-survivors” denote survival to hospital discharge. As a control
roup, we included 10 subjects without brain injury. Seven controls
ere patients admitted to the ICU for pre-operative hemodynamic
ptimization one day before esophagectomy. Three controls were
ealthy volunteers who participated in an experimental study.
hese healthy volunteers were included after written informed
onsent and approval of the protocol by the local Institutional
eview Board. For the patients after cardiac arrest and patients
dmitted for hemodynamic optimization the local Institutional
eview Board waived the need for informed consent. Exclusion cri-
eria for all patients were an irregular heart rhythm, insufﬁcient
ranstemporal bone window, pregnancy, thrombolytic therapy,
efractory cardiogenic shock or a life expectancy <24 h.
atient management
The post-cardiac arrest patients were treated with hypothermia
y rapid infusion of 30 mL/kg bodyweight of cold Ringer’s lactate
t 4 ◦C followed by external cooling using two water-circulating
lankets (Blanketroll II, Cincinnati Subzero, The Surgical Company,
mersfoort, The Netherlands). Temperature was  maintained at
2–34 ◦C for 24 h, followed by passive rewarming to normother-
ia  (deﬁned as 37 ◦C). Cardiac arrest patients were sedated withcitation 110 (2017) 85–89
midazolam and/or propofol and sufentanil. Sedation was stopped
as soon as temperature was ≥36 ◦C. In case of shivering, patients
were paralyzed using intravenous bolus injections of rocuronium.
All patients were intubated and mechanically ventilated to obtain
PaO2 >75 mmHg  and PaCO2 34–41 mmHg. Mean arterial pres-
sure (MAP) was maintained between 80–100 mmHg. If necessary,
patients were treated with volume infusion and dobutamine and/or
milrinone and/or noradrenaline (norepinephrine).
Controls were admitted to the ICU the day before surgery for
hemodynamic optimization or to the research unit of the ICU. All
measurements in this group were performed while subjects were
awake, without mechanical ventilation and before ﬂuid resuscita-
tion, pre-operative or study related interventions were initiated.
Data collection
Demographic, pre-hospital and clinical data were collected
upon and during admission. An arterial catheter was used for mon-
itoring of blood pressure in all subjects.
MFV  in the middle cerebral artery (MFVMCA) was measured by
TCD through the temporal window with a 2-Mhz probe (Multi-
Dop T Digital, Compumedics DWL, Singen, Germany) according to
the method developed by Aaslid et al.14 The probe was positioned
over the temporal bone window above the zygomatic arch and
ﬁxed. This procedure ensured that the angle and individual depth of
insonation remained constant during investigation. The temporal
acoustic window and Doppler depth giving the highest velocities
were used for all measurements. Two investigators performed all
measurements (J.B. and C.H.). Recordings were made with subjects
in supine position, the head elevated to 30◦.
A minimum of 10–12 min  windows of MFV, heart rate and
arterial blood pressure (ABP) were simultaneously recorded on a
computer and stored on a hard disk with a sample rate of 200 Hz
by an A/D converter (NI USB-6211, National Instrument, Austin,
TX, USA). During the measurements, PaO2, PaCO2 and temperature
were within normal ranges and patients were normotensive.
In patients after cardiac arrest, measurements were performed
on admission to the ICU and at 6, 12, 24, 36, 48, 60 and 72 h. Subjects
in the control group were measured once.
Data analysis
ABP and MFV  data were analyzed using custom-written MAT-
LAB scripts (Matlab R2014b, The MathWorks Inc., Massachusetts,
USA). First, the time series were ﬁltered with an 5th-order low-pass
Butterworth ﬁlter (25 Hz), to ascertain signal stationarity. Second,
periods of 5 min  of artefact- and calibration-free data were selected
by visual inspection for subsequent analysis. Last, mean blood pres-
sure and cerebral blood ﬂow velocity were obtained synchronically
using a 4th order low-pass Butterworth ﬁlter.
CrCP
CrCP was determined according to the method suggested by
Varsos et al.10,15
CrCP = ABP − CPP√
(CVR · Ca · HR · 2)2 + 1
With CVR cerebrovascular resistance, Ca compliance of the vas-
cular bed and HR heart rate. The multiplication of CVR and Ca is
called the time constant Tau (). CPP is deﬁned as ABP − ICP, how-
ever in this study ICP was  not measured. Therefore ABPmean was
used as an approach of CPP, as described by Varsos et al.10 CVR was
calculated by dividing ABPmean by MFVmean. To determine Ca,
cerebral arterial blood volume (CABV) was  calculated by integrat-
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Table  1
Demographic data cardiac arrest patients and controls.
Characteristic Cardiac arrest Control P value
Number of patients, n 11 10
Male, n (%) 9 (81%) 8 (80%)
Age (years) 57[55–61] 65[31–67] 0.75
SAPS II 60[41–69] 13[7.3–18] <0.001
APACHE II 26[24–30] 4.5[0.8–9.0] <0.001
Number of survivors, n (%) 7 (64%) 10 (100%) 0.36
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Fig. 1. MFV  of survivors and non-survivors in comatose patients succesfully resus-
citated from a cardiac arrest and treated with mild hypothermia, during 72 h of ICU
0.10[0.08–0.16] mmHg/cm3 at 72 h (P = 0.02), with no differences
between survivors and non-survivors (P = 0.81) (data not shown).APS II: Simpliﬁed Acute Physiology Score II.
PACHE II: Acute Physiology and Chronic Health Evaluation II.
ng the MFV  signal over time. Then Ca was calculated by dividing
he amplitude of the ﬁrst harmonic of the CABV by the amplitude of
he ﬁrst harmonic of the ABP. HR was deﬁned as the ﬁrst harmonic
requency of ABP.
tatistical analysis
Statistical analysis was performed using GraphPad Prism ver-
ion 5.0 (GraphPad Software, La Jolla, CA). Data are presented as
edian with 25th and 75th percentile. Figures also show minimum
nd maximum (whiskers) values. Changes over time were analyzed
ith the repeated-measures test for nonparametric data. Differ-
nces between survivors and non-survivors were analyzed with
wo-way analysis of variance. The Mann Whitney test was used for
omparison between groups. A P-value of <0.05 was considered to
ndicate signiﬁcance.
esults
emographic and clinical data
We  included 9 male and 2 female (n = 11) comatose patients
fter cardiac arrest. The demographic data of the patients and con-
rols are shown in Table 1. Eight patients had ventricular ﬁbrillation
r ventricular tachycardia as initial rhythm, 3 patients initially had
 pulseless electrical activity or asystole Four patients died in the
CU, all as result of severe postanoxic brain damage. The clinical
ata are summarized in Table 2. Cardiac arrest patients had a sig-
iﬁcantly higher hemoglobin on admission (P = 0.03). The pH was
ower (P = 0.002) and the arterial carbondioxide tension was  signif-
cantly higher (P = 0.01) immediately after cardiac arrest compared
o normal control patients.
erebral blood ﬂow velocityAs expected, MFV  increased signiﬁcantly after cardiac arrest
rom 28.0[25.0–39.0] upon ICU admission to 78.0[65.0–123.0] cm/s
fter 72 h, P < 0.001 (Fig. 1). The MFVMCA was  similar in sur-
able 2
linical and laboratory data.
Characteristic Cardiac arresta Normal P value
Mechanical ventilation 11 (100%) 0 (0%)
MAP  (mmHg) 91.0[84.5–114.5] 91.1[86.3–105.1] 0.92
Heart rate (bpm) 85.0[80.0–92.0] 69.5[62.5–76.5] 0.09
Temperature (◦C) 35.5[34.3–35.9] 37.0[36.8–37.1] 0.006
Noradrenaline 1 (9.1%) 0 (0%)
Dose (g/kg/min) 0.12
Milrinone 0 (0%) 0 (0%)
Dobutamine 0 (0%) 0 (0%)
Hemoglobin (g/dL) 14.7[12.9–14.7] 11.6[10.8–12.6] 0.03
pH  7.31[7.26–7.37] 7.45[7.43–7.46] 0.002
PaO2 (mmHg) 102[81–168] 87[78–105] 0.28
PaCO2 (mmHg) 42.0[39.0–43.5] 35.6[34.5–36.8] 0.01
a Data represent values upon admission to the ICU.admission.
MFV  = mean ﬂow velocity.
vivors and non-survivors upon admission to the ICU, but the
MFVMCA increased stronger in non-survivors compared to sur-
vivors throughout the observation period (P = 0.001). MFVMCA was
signiﬁcantly lower in survivors immediately after cardiac arrest
compared to normal controls (P < 0.001), with a gradual restoration
toward normal values.
MAP  decreased after cardiac arrest from 91.0[83.0–123] on
admission to 82.5[77.8–87.8] at 48 h and 88.0[83.0–98.0] mmHg at
72 h (P = 0.009) with no signiﬁcant differences between survivors
and non-survivors (P = 0.09) (data not shown). MAP  in the control
patients was  92.6[86.3–105.1] and comparable to the cardiac arrest
group (data not shown).
Critical closing pressure
After cardiac arrest, the CrCP decreased signiﬁcantly from
61.4[51.0–77.1] on admission to 41.7[39.9–51.0] mmHg at 48 h,
after which it remained stable (P < 0.001), (Fig. 2). The CrCP
was signiﬁcantly higher in survivors compared to non-survivors
(P = 0.002). The CrCP immediately after cardiac arrest was signiﬁ-
cantly higher compared to the control group (P = 0.02).
The Ca represents the change of arterial blood volume in
response to change in arterial pressure and is estimated as a ratio
of pulse amplitude of CABV derived from the cerebral blood ﬂow
velocity and pulse amplitude of the ABP. After cardiac arrest, Ca
increased signiﬁcantly from 0.05[0.05–0.08] upon admission toCa values immediately after cardiac arrest were signiﬁcantly
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Fig. 2. CrCP of survivors and non-survivors in comatose patients succesfully resus-
citated from a cardiac arrest and treated with mild hypothermia, during 72 h of ICU
admission.
CrCP  = critical closing pressure.
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Fig. 3. CVR of survivors and non-survivors in comatose patients succesfully resus-
citated from a cardiac arrest and treated with mild hypothermia, during 72 h of ICU
admission.
CVR = cerebrovascular resistance.
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Fig. 4. Tau (time constant) of survivors and non-survivors in comatose patients
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We  compared the cardiac arrest patients upon admission touccesfully resuscitated from a cardiac arrest and treated with mild hypothermia,
uring 72 h of ICU admission.
ower compared to normal values (0.11[0.08–0.25] mmHg/cm3,
 = 0.007).
The CVR is the resistance of small cerebral arteries and arte-
ioles and was estimated from the ABP and cerebral blood ﬂow
elocity. The initial CVR in patients after cardiac arrest was
igh (3.91[2.94–5.37]) and signiﬁcantly decreased after 72 h to
.35[0.88–1.81] mmHg  s/cm (P < 0.001), with a stronger decline in
on-survivors (P = 0.02), (Fig. 3). The CVR on admission was sig-
iﬁcantly higher in the cardiac arrest group compared to normal
ontrols (1.67[1.25–2.62] mmHg  s/cm, P < 0.001).
Tau () is the time constant of cerebral arterial bed and is the
roduct of brain arterial compliance Ca and CVR. It estimates how
ast cerebral blood arrives in the cerebral arterial bed during each
ardiac cycle. Tau decreased signiﬁcantly from 0.22[0.19–0.26]
o 0.13[0.11–0.20] s (P = 0.005), with a stronger decrease in non-
urvivors compared to survivors (P = 0.01) (Fig. 4). Tau in the control
roup was 0.18[0.15–0.25] s, and did not differ signiﬁcantly from
alues on admission after cardiac arrest.
iscussion
Cerebral hemodynamic parameters change signiﬁcantly after
ardiac arrest. MFVMCA is low in the ﬁrst hours after cardiac arrest,
ith a high CrCP and CVR. During the ﬁrst 72 h, the MFV  gradually
ncreases toward normal values, with a concomitant decrease in
rCP and CVR. This change in cerebrovascular proﬁle after cardiac
rrest is most likely the result of a change in cerebrovascular motor
one, switching from vasoconstriction at admission to vasodilation
fter 72 h.citation 110 (2017) 85–89
CrCP is the sum of cerebral artery smooth muscle tone and ICP.8
In theory, changes in CrCP can originate from changes in both com-
ponents. Most likely, the increased CrCP after cardiac arrest is the
result of cerebral vasoconstriction in the ﬁrst hours after ROSC.
In our patients, the resistance of small cerebral arteries and arte-
rioles, estimated by the CVR, was high and gradually decreased
toward normal values. In humans, the transcranial Doppler pul-
satility index of the MCA  is high during the early post-cardiac
arrest period and decreases toward normal values after 24–48 h,2–4
also implicating increased cerebral arterial resistance. The com-
bination of low cerebral blood ﬂow velocities with high CVR is
a characteristic of the “delayed cerebral hypoperfusion phase”
described in post-resuscitation animal models.1 An imbalance
between local vasoconstrictors and vasodilators, characterized by
high endothelin levels, gradually decreasing nitrate concentrations,
and gradually increasing cGMP levels is suggested to underlie the
cerebral perfusion changes after cardiac arrest.3 Other factors that
contribute to this reduced blood ﬂow include a reduction in neu-
ronal activity, vasospasm, edema, platelet and leukocyte adhesion
and changes in viscosity.1,3,16–19
The incidence of intracranial hypertension after cardiac arrest
is unknown, and has been studied in only a small number of highly
selected patients.20–24 In those patients, ICP upon admission to the
ICU was  low, even in patients who  developed intracranial hyper-
tension later during the course of admission.21 As CrCP was  high on
admission and decreased in the ﬁrst hours after ROSC, increased ICP
is probably not a major factor determining CrCP in our population.
This is supported by the fact that CrCP was  lower in non-survivors
compared to survivors, whereas post-cardiac arrest patients with
intracranial hypertension (resulting in high CrCP) had a poor out-
come in all studies.20–24
Our results stress the importance of maintaining a sufﬁciently
high cerebral perfusion pressure, especially in the ﬁrst hours after
cardiac arrest to avoid secondary brain ischemia. Our data sug-
gest that the widely used MAP  range of 65–70 mmHg  is probably
suboptimal.25 This is in agreement with a previous study on the
optimal cerebral perfusion pressure after cardiac arrest, suggesting
an optimal MAP  between 85–105 mmHg.6
Survivors and non-survivors revealed signiﬁcantly different
cerebral perfusion characteristics during the post-cardiac arrest
period. Non-survivors showed a more pronounced increase in
MFVMCA in the ﬁrst 72 h after the arrest. This was accompanied
by a stronger decrease in CrCP and CVR in non-survivors. Differ-
ences in systemic parameters such as MAP, pH or PaCO2 tension
or differences in use of vaso-active drugs did not account for these
differences in cerebral perfusion. These data are in accordance with
previous observations of a signiﬁcant decrease in pulsatility index
and an increase in MFVMCA in non-survivors after cardiac arrest.5
Apparently, vasoactive tone is lost in patients with poor outcome,
resulting in a decrease in CVR and subsequently an increase in
cerebral blood ﬂow. Under normal circumstances, cerebral blood
ﬂow is maintained at a constant level through the mechanism
of cerebrovascular autoregulation. Autoregulation is disturbed in
approximately 1/3 of patients after cardiac arrest, mainly in those
with poor outcome.6,7 A loss of autoregulation may have resulted
in increased blood ﬂow with low CVR in the non-survivors. In
addition, the ischemia-reperfusion response activates a large num-
ber of pathophysiological pathways including oxidative stress,
inﬂammation and coagulation resulting in reactive hyperemia.26,27
This reactive hyperemia is likely to be more pronounced in more
severely affected patients, explaining the increased ﬂow with low
resistance in non-survivors.normal control subjects. MFVMCA was signiﬁcantly lower imme-
diately after cardiac arrest compared to normal control patients.
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transient forebrain ischemia in rats: involvement of type I nitric oxide synthase.J.M.D. van den Brule et al. /
rCP and CVR were higher compared to controls. Use of sedatives
nd vasopressors is common during the post-cardiac arrest period
nd may  inﬂuence the cerebrovascular perfusion characteristics.
ormal control patients were measured without any sedatives or
asopressive agents. The post-resuscitation perfusion pattern was
ifferent in survivors versus non-survivors, despite similar levels
f blood pressure, use of sedatives and vasopressors and labora-
ory values, strongly suggesting a distinct pathophysiological entity
ather than an ICU or drug-induced effect on cerebral blood ﬂow.
A unique feature of the treatment after cardiac arrest was the
se of mild hypothermia in our patients. Hypothermia may  delay
estoration of cerebral blood ﬂow toward normal values, but does
ot alter the pattern of hypoperfusion followed by normal or hyper-
erfusion and is probably not a major determinant of the cerebral
lood ﬂow after cardiac arrest.2,28 The contribution of hypothermia
o the high CrCP and CVR upon admission cannot be established
rom this study, but seems relatively minor since both CrCP and
esistance decrease while temperatures decline in the ﬁrst hours
fter admission.
This study has a number of limitations. First, CrCP cannot be
easured in vivo but is estimated using a mathematical model,
ith its inherent risks of bias. Most importantly, ICP is required for
 most accurate calculation of the model. Since ICP is low under
ormal conditions, it does not signiﬁcantly alter the estimation of
rCP. ICP is unlikely to have a major inﬂuence on our results, as CrCP
ecreases in non-survivors (whereas raised ICP would increase
rCP). We  measured ABP through a catheter in the radial artery.
easurement of the ABP in the MCA  would have resulted in a more
ccurate estimation of cerebral perfusion pressure but is not feasi-
le in patients. Second, the cerebral perfusion changes after cardiac
rrest are probably heterogeneously distributed through the brain,
ith some areas more affected than others. As CrCP is derived
rom the MFVMCA, these heterogeneities cannot be measured by
his technique. This study also has limitations inherent in com-
aring subjects with regimented hemodynamics and ventilation
o awake control subjects. ABP and HR are both components in the
ethod of Varsos, but there were no signiﬁcant differences in these
omponents between cardiac arrest patients and normal controls.
nother component in the method of Varsos is MFV, which is inﬂu-
nced by the diameter of the MCA  and thus by pH/carbondioxide
ension. pH/carbondioxide tension was different between cardiac
rrest patients and normal controls on admission and may  have
ffected the results, but this component normalized early after
dmission.
Although we studied only 11 patients, the results appear to be
hysiologically sound.
onclusions
In conclusion, CrCP is high after cardiac arrest with high cere-
rovascular resistance and low cerebral blood ﬂow velocities. This
uggests that cerebral perfusion pressure should be maintained at
 sufﬁcient high level to avoid secondary brain injury. Failure to
ormalize the cerebrovascular proﬁle may  be a parameter of poor
utcome.onﬂict of interest statement
No conﬂicts of interest.
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